AMSBIO has launched a new 2024 travel grant award scheme for scientists under the age of thirty, employed in academia, research institutions, or companies engaged in cancer and stem cell research.
News
- Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived Organ-on-a-Chip solution for more accurate in vitro ADME predictions
- Early access to dual-organ model available through CN Bio’s Contract Research Services
In the first People Pathways edition of the year, we are thrilled to bring you our 4th annual Building Life Sciences Adventures (BLSA) Conference and wanted to share a glimpse of the exiting journey that lies ahead.
Click here to read about:
✳ Top 5 reasons why you should sponsor BLSA...
Excitement is in the air as we approach our Annual Awards Dinner on 21 March 2024, at stunning London venue, No.11 Cavendish Square.
Get your nominations in and be part of an evening that recognises and celebrates the success of our community. Remember, you have the opportunity to nominate either your own company or a company you've worked with to acknowledge their exceptional performance. Entries close on 7 February.
Categories
Chesterford Research Park, set in over 250 acres of idyllic countryside, makes business meetings an unexpected pleasure, training and team building exercises a talking point and even the simplest of functions memorable.
Mayer Schreiber, CEO of Discovery Park, and Chris Broom, Head of Business Development at Discovery Park, recently attended the JP Morgan Healthcare Conference in San Francisco to build global connections and raise awareness of the opportunities in the UK for the biotech industry, as well as exploring opportunities for Discovery Park Ventures and its portfolio companies. The conference brought together thousands of industry experts from across the globe to discuss the biggest challenges and opportunities for 2024 and beyond.
MedFlow Clinical has been recognised as a global top 10 clinical trial supply company by Life Sciences Review. Read the full story...
MedFlow Clinical: Revolutionising Clinical Trial Supply Management
Specialist preclinical contract research organisation (CRO) Cellomatics Biosciences has heralded the start of its next successful phase with four promotions and eight new arrivals.
Dr Shailendra Singh, CEO of Cellomatics Biosciences, comments: “Capitalising on our existing strengths and internal team expertise, we intend to further consolidate our position as a specialist biology CRO by broadening and deepening our service offerings in 2024. With these new appointments and internal restructuring, we are poised to catapult ourselves to the next phase of our growth journey.”
Check out the Bristows Biotech Review of the Year. This report reflects on the key developments in the biotech industry, including:
- Legal updates
- Generative AI
- The Unified Patent Court
- CRISPR technology
- Predictions for 2024